# Security and Data-Integrity Review

## Verdict

Adequate for implementation planning; production remains correctly gated on external privacy, ethics, clinical, and vendor approvals.

## Coverage

- Authentication, MFA separation, short access tokens, local revocation, least privilege, re-identification step-up, and abuse controls are fixed.
- Pseudonymization, insert-only Source Records, atomic audit, digest anchoring, controlled export, policy-driven retention, and distinct KMS purposes prevent common silent data-integrity failures.
- Private networking, separate accounts, synthetic non-production data, secrets rotation, redacted telemetry, DLQs, and restore/release rehearsal cover the operational envelope.
- Video tolerances are explicit and limited to encoding precision, preserving the product’s no-forward-skip invariant.

## Residual gates

- Threat model, privacy impact assessment, penetration test, vendor transfer assessment, SMS anti-fraud limits, incident runbooks, and restore evidence must be completed before production Study activation.
